# Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria

> **NCT02012985** · PHASE1,PHASE2 · COMPLETED · sponsor: **OxThera** · enrollment: 28 (actual)

## Conditions studied

- Primary Hyperoxaluria

## Interventions

- **BIOLOGICAL:** Oxabact OC5 capsules
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT02012985
- **Lead sponsor:** OxThera
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2015-10-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02012985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02012985, "Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02012985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*